Ganaxolone
( DrugBank: Ganaxolone / KEGG DRUG: Ganaxolone )
4 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 145 | West syndrome | 5 |
| 152 | PCDH19 related syndrome | 10 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 158 | Tuberous sclerosis | 8 |
| 206 | Fragile X syndrome | 2 |
145. West syndrome
Clinical trials : 49 / Drugs : 43 - (DrugBank : 16) / Drug target genes : 29 - Drug target pathways : 28
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
152. PCDH19 related syndrome
Clinical trials : 11 / Drugs : 4 - (DrugBank : 1) / Drug target genes : 16 - Drug target pathways : 8
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
158. Tuberous sclerosis
Clinical trials : 129 / Drugs : 56 - (DrugBank : 20) / Drug target genes : 35 - Drug target pathways : 116
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
206. Fragile X syndrome
Clinical trials : 118 / Drugs : 75 - (DrugBank : 30) / Drug target genes : 58 - Drug target pathways : 83
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|